Laurus Labs

LAURUSLABS · NSE · INR

₹1,973.20Change from previous close: −0.54%Absolute change: −₹10.80

Close · October 5, 2026

Company profile

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Jubilee Hills, 500033, Hyderabad
Employees
7,059
Listing
LAURUSLABS · NSE
Currency
INR